.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Argus Health
Cipla
Cantor Fitzgerald
Accenture
Medtronic
Baxter
Julphar
Fuji
Chinese Patent Office

Generated: September 26, 2017

DrugPatentWatch Database Preview

Ziprasidone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ziprasidone hydrochloride and what is the scope of ziprasidone hydrochloride freedom to operate?

Ziprasidone hydrochloride
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Pfizer, Wockhardt Ltd, Lupin Pharms, Apotex Inc, Sandoz Inc, Dr Reddys Labs Inc, Macleods Pharms Ltd, Pfizer Inc, Zydus Pharms Usa Inc, and Mylan Pharms Inc, and is included in eleven NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ziprasidone hydrochloride has one hundred and twenty-nine patent family members in fifty-three countries.

There are twenty-one drug master file entries for ziprasidone hydrochloride. Thirty-three suppliers are listed for this compound.

Summary for Generic Name: ziprasidone hydrochloride

Tradenames:2
Patents:3
Applicants:11
NDAs:11
Drug Master File Entries: see list21
Suppliers / Packagers: see list33
Bulk Api Vendors: see list162
Clinical Trials: see list2,400
Patent Applications: see list4,952
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ziprasidone hydrochloride at DailyMed

Pharmacology for Ingredient: ziprasidone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-001Feb 5, 2001ABRXYesYes► Subscribe► Subscribe ► Subscribe
Zydus Pharms Usa Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL208988-002Aug 22, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL202395-002Oct 10, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Pharms
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL077560-001Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL208988-003Aug 22, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-004Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Dr Reddys Labs Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL077565-001Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
GEODON
ziprasidone hydrochloride
SUSPENSION;ORAL021483-001Mar 29, 2006DISCNNoNo► Subscribe► Subscribe ► Subscribe
Pfizer
GEODON
ziprasidone hydrochloride
CAPSULE;ORAL020825-003Feb 5, 2001ABRXYesNo► Subscribe► Subscribe ► Subscribe
Macleods Pharms Ltd
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL204375-002Feb 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ziprasidone hydrochloride

International Patent Family for Ingredient: ziprasidone hydrochloride

Country Document Number Estimated Expiration
China1307994► Subscribe
TunisiaSN00112► Subscribe
Austria231394► Subscribe
Malaysia121397► Subscribe
Hungary9802958► Subscribe
New Zealand333436► Subscribe
New Zealand336271► Subscribe
Eurasian Patent Organization003907► Subscribe
Australia3398399► Subscribe
Germany60001649► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
US Army
Fish and Richardson
Federal Trade Commission
AstraZeneca
UBS
Johnson and Johnson
Healthtrust
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot